Journal Watch - Chronic kidney disease

« Back to Most Recent

  • Mucomyst does not prevent nephrogenic systemic sclerosis

    A new study randomized 2,308 people at risk for kidney injury from contrast dye into two groups. One group was given acetylcysteine (Mucomyst®) by mouth, a strong antioxidant. The other group was given a placebo. Both groups had the same rate of kidney injury and need for dialysis.

    Read the abstract » | (added 2011-09-29)

    Tags: Chronic kidney disease

  • Ratios of Omega-6 to Omega-3 fats may impact health in kidney disease

    Western diets tend to have too much omega 6 and not enough omega 3 fatty acids. In 145 people on standard in-center HD, having too much omega 6 was linked with significantly higher inflammation.

    Read the abstract » | (added 2011-07-26)

    Tags: Chronic kidney disease

  • The frontier of regenerative medicine—what it can mean for kidney disease

    While dialysis can remove wastes and excess water from the blood, it can't replace or respond to hormones like healthy kidneys do. Regenerative medicine is at the cutting edge of efforts to grow kidney cells in the lab—with the goal of one day growing new kidneys. And, that day may not be far off.

    Read the abstract » | (added 2011-07-26)

    Tags: Chronic kidney disease

  • CKD education rates in Australia (they're FAR better than in the US!)

    It's hard to choose a treatment option for kidney failure that fits your life when you don't know what the options are, or how they might affect you. A study of 721 people new to dialysis in Australia found that 603 (84%) had options education before they started treatment.

    Read the abstract » | (added 2011-05-23)

    Tags: Chronic kidney disease

  • New model using routine lab tests can predict progression to kidney failure

    Researchers looked at data from a total of 8,391 people with stages 3–5 CKD to see if lab test results could predict who would progress to end-stage. A model that included age, sex, GFR, and protein in the urine worked best.

    Read the abstract » | (added 2011-05-23)

    Tags: Chronic kidney disease

  • Oral adsorbents may help reduce levels of uremic toxins

    The colon makes some wastes that are removed by the kidneys. So, drugs that keep these wastes from getting into the bloodstream could help keep them from building up in the body when the kidneys fail.

    Read the abstract » | (added 2011-04-25)

    Tags: Chronic kidney disease

  • Chemical ablation to correct recurrent secondary hyperparathyroidism post parathyroidectomy

    Reoperation after a parathyroidectmy can be risky. In a study of 49 people, injecting ethanol (alcohol) into the gland, guided by ultrasound, helped to lower PTH levels without more surgery.

    Read the abstract » | (added 2011-04-25)

    Tags: Chronic kidney disease

  • People want treatments that offer FREEDOM

    A new study interviewed 52 people who were on one of 4 types of dialysis or had a transplant—and learned that "freedom, convenience, self-care, effectiveness, and simplicity" were important. (We could have told you that.)

    Read the abstract » | (added 2011-02-24)

    Tags: Chronic kidney disease

  • Matching home dialysis to lifestyle

    A "continuum home program concept" described in a new article would help people with kidney failure continue their lifestyles with dialysis—rather than disrupt them with treatment. The aim is for a continuous flow of services from education to treatment choice, dialysis access, and option changes when needed.

    Read the abstract » | (added 2011-02-24)

    Tags: Chronic kidney disease

  • No tested CKD decision aids available

    A meta-analysis of 40 studies looks at how people with CKD decide which treatment to choose. The 4 key factors were:

    1. Personal relationships
    2. Keeping current well-being, normality, and quality of life
    3. Need for control
    4. Benefits vs. risks
    No reliable, tested decision aids are available—yet.

    Read the abstract » | (added 2011-02-24)

    Tags: Chronic kidney disease